Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen

Chemotherapy-induced posterior reversible encephalopathy (PRES) syndrome is a rare event. Its recurrence after reusing the incriminated molecules remains unpredictable. We report the case of a 58-year-old female patient being followed for a diffuse large B-cell lymphoma treated with rituximab, cyclo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jennane, Selim, Mahtat, El Mehdi, Ababou, Mounir, El Maaroufi, Hicham, Doghmi, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191265/
https://www.ncbi.nlm.nih.gov/pubmed/35719806
http://dx.doi.org/10.7759/cureus.24988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191265/
https://www.ncbi.nlm.nih.gov/pubmed/35719806
http://dx.doi.org/10.7759/cureus.24988

Ejemplares similares